HDSN(HDSN)
HDSN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $253M | $259M |
| Low | $250M | $253M |
| High | $256M | $265M |
| EBITDA Avg | $64M | $65M |
| Low | $63M | $64M |
| High | $64M | $66M |
| EBIT Avg | $57M | $59M |
| Low | $57M | $57M |
| High | $58M | $60M |
| Net Income Avg | $16M | $19M |
| Low | $14M | $18M |
| High | $18M | $19M |
| EPS Avg | $0.38 | $0.44 |
| Low | $0.34 | $0.42 |
| High | $0.41 | $0.45 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $75M | $44M | $65M | $75M | $74M | $44M |
| Low | $74M | $43M | $63M | $73M | $72M | $43M |
| High | $75M | $45M | $66M | $77M | $76M | $45M |
| EBITDA Avg | $19M | $11M | $16M | $19M | $19M | $11M |
| Low | $19M | $11M | $16M | $18M | $18M | $11M |
| High | $19M | $11M | $17M | $19M | $19M | $11M |
| EBIT Avg | $17M | $10M | $15M | $17M | $17M | $10M |
| Low | $17M | $10M | $14M | $17M | $16M | $10M |
| High | $17M | $10M | $15M | $17M | $17M | $10M |
| Net Income Avg | $9M | $-638,641 | $4M | $8M | $9M | $-425,760 |
| Low | $9M | $-656,419 | $4M | $8M | $9M | $-437,613 |
| High | $10M | $-614,987 | $4M | $8M | $9M | $-409,991 |
| EPS Avg | $0.21 | $-0.01 | $0.09 | $0.19 | $0.21 | $-0.01 |
| Low | $0.20 | $-0.02 | $0.09 | $0.18 | $0.20 | $-0.01 |
| High | $0.22 | $-0.01 | $0.09 | $0.20 | $0.22 | $-0.01 |
| Analysts (Rev / EPS) | 3 / 2 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |